4SC AGの収益Y / Y
4SC AGの収益Y / Yは何ですか。
4SC AGの収益Y / Yは-7.80%です。
収益Y / Yの定義は何ですか。
過去3年間の年間収益の伸びは、過去3年間で平均した1年間の収益成長率です。
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
XETRAのセクタHealth Careにおける収益Y / Yの企業と比べる4SC AG
4SC AGは何をしますか。
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.
4SC AGと類似の収益y / y
- Sunrise Realty Trustの収益Y / Yは-7.81%です。
- John Hancock Preferred Income Fund IIの収益Y / Yは-7.81%です。
- First Interstate BancSystemの収益Y / Yは-7.81%です。
- Conns Incの収益Y / Yは-7.81%です。
- Jubilant Life Sciencesの収益Y / Yは-7.81%です。
- QUIZ Plcの収益Y / Yは-7.80%です。
- 4SC AGの収益Y / Yは-7.80%です。
- Nufarmの収益Y / Yは-7.80%です。
- HM Internationalの収益Y / Yは-7.79%です。
- Standard AVBの収益Y / Yは-7.78%です。
- 36Kr Incの収益Y / Yは-7.77%です。
- Natural Health Trendsの収益Y / Yは-7.77%です。
- Technicolor SAの収益Y / Yは-7.77%です。